Two distinct alpha1-adrenergic receptor sites in rat liver: differential binding of (--)-[3H]dihydroergocryptine. Effects of guanine nucleotides and proteolysis; implications for a two-site model of alpha-receptor regulation.
D000818:Animals; D001665:Binding Sites; D002918:Chymotrypsin / Q000494:pharmacology; D004088:Dihydroergotoxine / Q000378:metabolism; D005260:Female; D006150:Guanine Nucleotides / Q000494:pharmacology; D066298:In Vitro Techniques; D008099:Liver / Q000378:metabolism*; D008956:Models, Chemical; D009638:Norepinephrine / Q000378:metabolism; D010643:Phenoxybenzamine / Q000494:pharmacology; D011224:Prazosin / Q000378:metabolism; D051381:Rats; D011941:Receptors, Adrenergic / Q000378:metabolism*; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects / Q000378:metabolism*
D006150:Guanine Nucleotides; D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D010643:Phenoxybenzamine; D004088:Dihydroergotoxine; D002918:Chymotrypsin; D009638:Norepinephrine; D011224:Prazosin